On the other side, glioblastomas that recur after therapy increased the amount and activation (phosphorylation) of proteins involved in synaptic formation, GTPase activity, and oxidative phosphorylation driven by the activity of RAS, BRAF, and MAPK proteins. The gene discussed is BRAF; the disease is glioblastoma.